Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03943134 · ClinicalTrials.gov registry record
Registry of Avive® Soft Tissue Membrane Utilization in Selected Applications of Acute Trauma of the Upper Extremity
A clinical trial, sponsored by Axogen Corporation.
- Terminated
- Registry status
- 7
- Enrollment target
NCT03943134 is a clinical trial that was terminated before completion, run by Axogen Corporation. The registered enrollment target is 7 participants.
The verdict
NCT03943134 was terminated before completion, sponsored by Axogen Corporation.
- TERMINATED
- Registry status
- 7 participants
- Enrollment target
Study Summary
A registry study to evaluate the role of Avive® Soft Tissue Membrane in the management of nerve injury associated with acute trauma in the upper extremity.
Interventions
- OTHER Minimally Processed Human Umbilical Cord Membrane
- OTHER Standard Surgical Procedures
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2018-12-01 |
| Est. Completion | 2020-12-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03943134
The ClinicalTrials.gov registry entry for NCT03943134 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Axogen Corporation, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Minimally Processed Human Umbilical Cord Membrane is the first listed.
NCT03943134 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03943134 about?
NCT03943134 is a clinical study titled "Registry of Avive® Soft Tissue Membrane Utilization in Selected Applications of Acute Trauma of the Upper Extremity". A registry study to evaluate the role of Avive® Soft Tissue Membrane in the management of nerve injury associated with acute trauma in the upper extremity.
What is the current status of trial NCT03943134?
This trial is currently terminated. The enrollment target is 7 participants. The study started on 2018-12-01. Estimated completion is 2020-12-17.
What interventions are being tested in trial NCT03943134?
The interventions under investigation include: Minimally Processed Human Umbilical Cord Membrane (OTHER), Standard Surgical Procedures (OTHER).
Who is sponsoring clinical trial NCT03943134?
This trial is sponsored by Axogen Corporation, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.